OXIRI [Oxaliplatin (O), Xeloda (X) and Irinotecan (I)] in Pancreatic Adenocarcinoma
Clinical trial NCT02368860 · COMPLETED
Trial details
- NCT number
- NCT02368860
- Sponsor
- National Cancer Centre, Singapore
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-17
- Primary completion
- 2020-05-21
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.